NCCN

Research in Review

Treatment Better Than Observation for Older Patients With Esophageal Cancer

05/03/2017

JCP Editors

Patients aged 80 years or older with early-stage esophageal cancer who received treatment had an increased 5-year overall survival (OS) compared with those who received no treatment or observation alone,...

...

05/03/2017

Journal of Clinical Pathways

Research in Review

Immune Checkpoint Inhibitor New Standard of Care for MSI-H Metastatic Colorectal Cancer

01/25/2017

JCP Editors

The immune checkpoint inhibitor nivolumab has shown durable responses and disease control in pretreated patients with DNA mismatch repair deficient/microsatellite instability high (MSI-H) metastatic colorectal...

The...

01/25/2017

Journal of Clinical Pathways

Research in Review

Noncompliance With NCCN Guidelines Can Worsen Rectal Cancer Survival

08/31/2016

JCP Editors

Not complying with recommendations found in National Comprehensive Cancer Network (NCCN) guidelines for locally advanced rectal cancer may led to worse overall survival, according to a study published in the journal...

Not...

08/31/2016

Journal of Clinical Pathways

Major Changes to NCCN Guidelines for Multiple Myeloma Announced

04/05/2016

JCP Editors

The National Comprehensive Cancer Network (NCCN) has announced three major changes to its guidelines for the treatment of multiple myeloma (MM) that broaden the population of patients eligible to start therapy,...

The...

04/05/2016

Journal of Clinical Pathways